Apple to Appeal US Import Ban on Latest Smartwatch Models

Apple has announced its intention to appeal the US import ban on its Series 9 and Ultra 2 smartwatch models, which came into effect recently. The ban was imposed due to a patent dispute with medical device maker Masimo Corporation. The US International Trade Commission (USITC) had ruled in October that Apple infringed on two of Masimo’s patents, leading to the ban.

The White House had the option to overturn the ban, but after careful consultations, they decided not to do so. Apple had previously removed the disputed smartwatch models from its US website and stores, but sales of these devices have not been affected in other countries.

The USITC’s decision has prompted Apple to file an emergency request with the US Court of Appeals, seeking to lift the ban. The company strongly disagrees with the ruling and is determined to return the Series 9 and Ultra 2 smartwatches to customers in the US as soon as possible.

Masimo Corporation, the medical device maker involved in the patent dispute, views the White House’s decision as a significant victory for the integrity of the US patent system. They believe that this decision will ultimately benefit American consumers by promoting an ecosystem that rewards true innovation.

In response to the ban, Apple has requested a stay on the decision until Customs and Border Protection (CBP) can consider whether the redesigned versions of its smartwatches, which do not include the disputed technology, violate Masimo’s patents. CBP is expected to make a decision on this matter on January 12th, according to an Apple spokesperson.

The Series 9 and Ultra 2 smartwatches in question have been popular among consumers due to their blood oxygen detection feature. However, the lower-cost SE model does not include this feature and will not be affected by the ban. Previously sold watches will also remain unaffected by the import restrictions.

In conclusion, Apple’s decision to appeal the US import ban on its latest smartwatch models highlights the company’s commitment to defending its products and technology. The outcome of this legal battle will have significant implications for both Apple and Masimo Corporation, as well as the broader technology industry.